Abstract
BackgroundPain is an under‐recognized complaint among head and neck cancer (HNC) survivors. Treatment is hindered by inadequate characterization of pain.MethodsA secondary analysis from a prospective, longitudinal study was conducted to characterize pain prevalence, quality, and functional consequences in 77 HNC patients. Pain and pain‐related outcomes were captured before treatment, at end‐of‐treatment, and 3, 6, 9 and 12 months post‐treatment.ResultsPain was most prevalent at end‐of‐treatment and declined over time. Chronicity of pain was established by 6 months post‐treatment. Oral mucosal neuropathic pain was the most common chronic pain subtype at 12 months post‐treatment. Widespread joint and muscle pain was also present at lower numbers. 40.2% of patients continued to require analgesics at 12 months.ConclusionPeripheral and central pain subtypes contribute significantly to chronic pain in HNC survivors. Preventive and treatment regimens should be tailored to specific pain subtypes for optimal symptom control.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
